Phase II, Step-wise, Randomized, Double-blind, Controlled Clinical Trial for Safety and Immunogenicity Evaluation of a Lyophilized Formulation of Dengue 1,2,3,4 (Attenuated) Vaccine in Healthy Adults
Latest Information Update: 06 Jan 2021
At a glance
- Drugs TV 003 (Primary)
- Indications Dengue
- Focus Adverse reactions; Pharmacodynamics
- 01 Oct 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 26 Sep 2013 Planned End Date changed from 1 May 2018 to 1 Dec 2018 as reported by ClinicalTrials.gov.
- 26 Sep 2013 Planned initiation date changed from 1 Nov 2012 to 1 Oct 2013 as reported by ClinicalTrials.gov.